We are live on ! Find out more
ELOX

Eloxx Pharmaceuticals, Inc. Common Stock
ELOX

Delisted

ELOX was delisted on the 13th of October, 2023.

Back to rankings

43 hedge funds and large institutions have $17.1M invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 46 → 43 (-3)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

35% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 20

73% less capital invested

Capital invested by funds: $64.1M → $17.1M (-$47.1M)

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
20
Closed
6
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
CI
Clal Insurance
Israel
+$2.36M
2
AS
Altshuler Shaham
Israel
+$188K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$159K
4
Northern Trust
Northern Trust
Illinois
+$111K
5
N
Nuveen
North Carolina
+$85.6K

Top Sellers

Rank Fund Capital Flow
1
MIH
Meitav Investment House
Israel
-$2.49M
2
Morgan Stanley
Morgan Stanley
New York
-$377K
3
Millennium Management
Millennium Management
New York
-$289K
4
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$231K
5
HF
HRT Financial
New York
-$170K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$29K -$3.58K -22 -6%
VOYA Investment Management
27
VOYA Investment Management
Georgia
$25K – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$24K +$50.3K +309 New
Citigroup
29
Citigroup
New York
$17K +$9.12K +56 +33%
Barclays
30
Barclays
United Kingdom
$16K -$69.5K -427 -67%
Deutsche Bank
31
Deutsche Bank
Germany
$16K -$2.12K -13 -6%
JP Morgan Chase
32
JP Morgan Chase
New York
$16K -$814 -5 -2%
Victory Capital Management
33
Victory Capital Management
Texas
$16K +$31.6K +194 New
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$15.3K +$15.3K +94 +93%
Bank of America
35
Bank of America
North Carolina
$12K -$48.2K -296 -66%
Legal & General Group
36
Legal & General Group
United Kingdom
$8K -$5.37K -33 -24%
SO
37
STRS Ohio
Ohio
$6K – – –
AIP
38
Ameritas Investment Partners
Nebraska
$4K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$4K +$2.12K +13 +33%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K -$6.35K -39 -66%
MAM
41
Meeder Asset Management
Ohio
$1K -$2.12K -13 -42%
RE
42
RBC Europe
United Kingdom
$29 – – –
MIH
43
Meitav Investment House
Israel
– -$2.49M -8,466 Closed
Millennium Management
44
Millennium Management
New York
– -$289K -982 Closed
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
– -$231K -853 Closed
HF
46
HRT Financial
New York
– -$170K -580 Closed
PP
47
Paloma Partners
Connecticut
– -$120K -408 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
– -$110K -373 Closed
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
– -$12.9K -79 -98%
Simplex Trading
50
Simplex Trading
Illinois
– -$2.12K -13 -93%
1
2

ELOX Hedge Fund Activity: Q1 2020 in Review

43 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q1 2020, worth a combined $17.1M — down 73% from $64.1M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ELOX and 4 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 13 added.

The largest buyer was Clal Insurance, adding an estimated $2.36M. The largest seller was Meitav Investment House, exiting entirely with an estimated $2.49M sold.

  • 43 institutional investors held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q1 2020, down from 46 in Q4 2019.
  • Funds reported $17.1M of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q1 2020, down 73% quarter-over-quarter.
  • 4 funds opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q1 2020 and 6 closed out, a net change of -2 holders.
  • The largest Eloxx Pharmaceuticals, Inc. Common Stock buyer in Q1 2020 was Clal Insurance, an estimated $2.36M added.
  • The largest Eloxx Pharmaceuticals, Inc. Common Stock seller in Q1 2020 was Meitav Investment House, an estimated $2.49M sold.

Based on aggregated 13F filings for Q1 2020.